FDA Approves Crestor to Reduce Stroke, Heart Attack Risk
Links shared publicly online about this topic.
- 1,393total visits
FDA Approves Crestor to Reduce Stroke, Heart Attack Risk
View full resource at drugs.com
Tags: Heart, Heart Disease, Cholesterol Medication, Heart Attack, Stroke, Thrombotic Event, FDA, Crestor
Most Recently Shared on February 9, 2010 at 11:44 pm By:
FDA Approves Crestor to Reduce Stroke, Heart Attack Risk - http://bit.ly/9Upmx3
AstraZeneca's CRESTOR: Health Canada approves new indication
news-medical.net — “AstraZeneca announced today that Health Canada has approved CRESTOR (rosuvastatin calcium) to reduce the risk of nonfatal myocardial infarction (heart attack), nonfatal stroke, and coronary artery revascularization in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease.” View full resource at news-medical.net
Most Recently Shared on March 17, 2010 at 2:22 pm By:
Stroke News: AstraZeneca's CRESTOR: Health Canada approves new indication: AstraZeneca announced today that Heal... http://twurl.nl/7ql3ku
FDA Approves New Indication for Crestor
fda.gov — “On Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it. The new indication is for reducing the likelihood of a heart attack or stroke or the need for a procedure to treat blocked or narrowed arteries in patients who have never been told they have heart disease but are nevertheless at increased risk of a cardiac event.” View full resource at fda.gov
Most Recently Shared on February 10, 2010 at 10:10 pm By:
Men's Health Network Health Organization
New drug indication for men aged 50+ (w/ elevated protein & cardio risk factor) to reduce likelihood of heart attack: http://ow.ly/1tOAD
US FDA Approves New Indication For CRESTOR® (Rosuvastatin Calcium)
medicalnewstoday.com — “AstraZeneca (NYSE: AZN) announced that the US Food and Drug Administration (FDA) has approved CRESTOR® (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction (heart attack)” View full resource at medicalnewstoday.com
Most Recently Shared on February 10, 2010 at 12:37 pm By:
US FDA Approves New Indication For CRESTOR® (rosuvastatin Calcium) AstraZeneca (NYSE: AZN) announced that the US Foo.. http://bit.ly/a4TRFd
FDA Approves MICARDIS(R) As The First Treatment In Its Class To Reduce The Risk Of Heart Attack, Stroke, Or Death From Cardiovascular Causes...
medicalnewstoday.com — “Boehringer ingelheim announced that the us food and drug administration (fda) has approved a new indication for micardis® (telmisartan) for the reduction of the risk of myocardial infarction (” View full resource at medicalnewstoday.com
Most Recently Shared on October 21, 2009 at 11:22 am By:
MedicalNewsToday: FDA Approves MICARDIS(R) As The First Treatment In Its Class To Reduce: http://bit.ly/2Am5jB Full http://bit.ly/423dI5
Press Releases
boehringer-ingelheim.com — “Press Releases” View full resource at boehringer-ingelheim.com
Most Recently Shared on October 19, 2009 at 1:51 pm By:
eyeonfda Pharma and Health Lawyer
FDA approves Micardis® (telmisartan) to reduce the risk of heart attack, stroke, or death from CV causes - http://bit.ly/Ye60M
Advertisement
